WendyLSacksMD

Endocrinology • Los Angeles, CA

Diabetes, Lipid Metabolism, Thyroid

Assistant Professor, Medicine, UCLA School of Medicine

Join to view full profile

Dr. Sacks is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Sacks' full profile

Already have an account?

Office
8700 Beverly Blvd.
Los Angeles, CA 90048

Education & Training

UCLA David Geffen School of Medicine/UCLA Medical CenterFellowship, Endocrinology, Diabetes, and Metabolism, 2006 - 2008
Cedars-Sinai Medical CenterResidency, Internal Medicine, 2003 - 2006
University of Tennessee Health Science Center College of MedicineClass of 2003

Certifications & Licensure

CA State Medical License 2004 - 2024

Awards, Honors, & Recognition

CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2013

Publications & Presentations

PubMed

28 citations
Expanded Parameters in Active Surveillance for Low-risk Papillary Thyroid Carcinoma: A Nonrandomized Controlled Trial.
Allen S Ho, Sungjin Kim, Cynthia Zalt, Michelle L Melany, Irene E Chen
JAMA Oncology. 2022-09-15
19 citations
Evolving approaches in managing radioactive iodine-refractory differentiated thyroid cancer.
Wendy Sacks, Glenn D. Braunstein
Endocrine Practice. 2014-03-01
126 citations
The effectiveness of radioactive iodine for treatment of low-risk thyroid cancer: a systematic analysis of the peer-reviewed literature from 1966 to April 2008.
Wendy Sacks, Constance H. Fung, John T. Chang, Alan D. Waxman, Glenn D. Braunstein
Thyroid. 2010-11-09

Press Mentions

Trifluridine/tipiracil in Patients with Metastatic Gastroesophageal Junction Cancer: A Subgroup Analysis from the Phase 3 TAGS StudyMarch 13th, 2021